Recurrent corneal erosions causing bacterial keratitis

Optometry : Journal of the American Optometric Association
Sandy Pham-Vang, David R Hardten

Abstract

Any etiology of epithelial defect can lead to severe bacterial keratitis. Patients with recurrent corneal erosions suffer repeated corneal epithelial defects without significant trauma and therefore are at risk of infectious keratitis more frequently than someone without recurrent erosions. A stromal infiltrate with an overlying area of epithelial defect can be challenging to differentiate between infectious and noninfectious inflammatory conditions. It is important for clinicians to appreciate the clinical findings in these cases and initiate aggressive treatment promptly. A 32-year-old woman presented with a history of anterior basement membrane dystrophy and recurrent corneal erosions. She had symptoms of redness, pain, foreign body sensation, photophobia, epiphora, and burning in her left eye that started 2 days before the visit to our office. Examination showed a large epithelial defect with dense stromal infiltrate inferiorly on the cornea that appeared white and milky with diffuse cellular infiltrate as well as 3+ cells in the anterior chamber. Laboratory results were positive for bacterial keratitis (Staphylococcus aureus). Infectious presentation should be considered visually threatening and treated immediately and agg...Continue Reading

References

Sep 1, 1978·Survey of Ophthalmology·G O WaringP R Laibson
Jun 15, 1991·American Journal of Ophthalmology·C R DavisonJ K Dart
Jun 15, 1988·American Journal of Ophthalmology·R M SteinP R Laibson
Jul 1, 1970·The British Journal of Ophthalmology·A H ChignellJ Thomsitt
Jul 1, 1997·The British Journal of Ophthalmology·A C IonidesP G Hykin
Nov 24, 1998·Acta Ophthalmologica Scandinavica·H M Tabery
Mar 24, 2000·The British Journal of Ophthalmology·N GangopadhyayH R Taylor
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J HobanR N Jones
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A C GalesR Ramphal
Jun 19, 2003·The British Journal of Ophthalmology·T BourcierL Laroche
Aug 21, 2003·The British Journal of Ophthalmology·M Daniell
Mar 3, 2004·Optometry : Journal of the American Optometric Association·Joseph Sowka
Feb 14, 2006·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Sri ThotaJan P G Bergmanson
Aug 2, 2006·Acta Ophthalmologica Scandinavica·Dominik VerhelstUNKNOWN Belgian Keratitis Study Group
Aug 21, 2010·Eye & Contact Lens·Peter R Laibson

❮ Previous
Next ❯

Citations

Mar 3, 2010·Indian Journal of Ophthalmology·Samrat Chatterjee, Deepshikha Agrawal
Oct 19, 2017·Tropical Doctor·Anita GangerRadhika Tandon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved